Risk factors of mortality after secondary procedures during the world-wide randomized antibiotic envelope infection prevention trial (WRAP-IT)

S. Mittal, J. Poole, C. Kennergren, U. Birgersdotter-Green, DL Lustgarten, GF Tomassoni, G. Hilleren, J. Lande, C. Lensing, B. Wilkoff, K. Tarakji
{"title":"Risk factors of mortality after secondary procedures during the world-wide randomized antibiotic envelope infection prevention trial (WRAP-IT)","authors":"S. Mittal, J. Poole, C. Kennergren, U. Birgersdotter-Green, DL Lustgarten, GF Tomassoni, G. Hilleren, J. Lande, C. Lensing, B. Wilkoff, K. Tarakji","doi":"10.1093/europace/euac053.524","DOIUrl":null,"url":null,"abstract":"\n \n \n Type of funding sources: Private company. Main funding source(s): Medtronic\n \n \n \n Previous analysis of WRAP-IT (World-wide Randomized Antibiotic Envelope Infection Prevention trial) data identified both patient and procedural characteristics as risk factors for cardiac implantable electronic device (CIED) infection. In the current analysis, we sought to similarly use prospectively collected WRAP-IT data to assess risk factors of all-cause mortality. Understanding if mortality risk can be modified and identifying baseline characteristics associated with high risk can help guide physician decision making.\n \n \n \n To identify modifiable and non-modifiable risk factors for 1-year all-cause mortality after a secondary (replacement, revision, or upgrade) CIED procedure.\n \n \n \n This analysis included 5,461 secondary procedure patients from the WRAP-IT study. Included as candidate factors were patient and procedural characteristics. Patients with more than one year follow-up were censored at one year. A multivariate Cox Proportional Hazards model was reached by stepwise selection to minimize Akaike Information Criterion.\n \n \n \n The overall one-year mortality rate was 5.2% after secondary procedures. Of the 26 patient and 18 procedural characteristics analyzed, the following variables best predicted risk of a 1-year all-cause mortality: age, NYHA class, renal dysfunction, anticoagulant use, ischemic cardiomyopathy, diabetes, BMI, procedure time, myocardial infarction, valve surgery, and hypertrophic cardiomyopathy (Table).\n \n \n \n In WRAP-IT patients undergoing secondary procedures, the only procedure characteristics that had any association with all-cause 1-year mortality risk was procedure time suggesting that most of the risk factors of mortality are non-modifiable. Baseline patient characteristics and co-morbidities were the principal risk factors of all-cause 1-year mortality. Specifically, increasing age, NYHA class, and a history of renal dysfunction were strongly associated with mortality.\n","PeriodicalId":11720,"journal":{"name":"EP Europace","volume":"74 3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EP Europace","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/europace/euac053.524","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Type of funding sources: Private company. Main funding source(s): Medtronic Previous analysis of WRAP-IT (World-wide Randomized Antibiotic Envelope Infection Prevention trial) data identified both patient and procedural characteristics as risk factors for cardiac implantable electronic device (CIED) infection. In the current analysis, we sought to similarly use prospectively collected WRAP-IT data to assess risk factors of all-cause mortality. Understanding if mortality risk can be modified and identifying baseline characteristics associated with high risk can help guide physician decision making. To identify modifiable and non-modifiable risk factors for 1-year all-cause mortality after a secondary (replacement, revision, or upgrade) CIED procedure. This analysis included 5,461 secondary procedure patients from the WRAP-IT study. Included as candidate factors were patient and procedural characteristics. Patients with more than one year follow-up were censored at one year. A multivariate Cox Proportional Hazards model was reached by stepwise selection to minimize Akaike Information Criterion. The overall one-year mortality rate was 5.2% after secondary procedures. Of the 26 patient and 18 procedural characteristics analyzed, the following variables best predicted risk of a 1-year all-cause mortality: age, NYHA class, renal dysfunction, anticoagulant use, ischemic cardiomyopathy, diabetes, BMI, procedure time, myocardial infarction, valve surgery, and hypertrophic cardiomyopathy (Table). In WRAP-IT patients undergoing secondary procedures, the only procedure characteristics that had any association with all-cause 1-year mortality risk was procedure time suggesting that most of the risk factors of mortality are non-modifiable. Baseline patient characteristics and co-morbidities were the principal risk factors of all-cause 1-year mortality. Specifically, increasing age, NYHA class, and a history of renal dysfunction were strongly associated with mortality.
世界范围随机抗生素包膜感染预防试验(WRAP-IT)中二次手术后死亡率的危险因素
资金来源类型:私人公司。主要资金来源:美敦力之前对WRAP-IT(全球随机抗生素包膜感染预防试验)数据的分析发现,患者和手术特征都是心脏植入式电子设备(CIED)感染的危险因素。在当前的分析中,我们试图类似地使用前瞻性收集的WRAP-IT数据来评估全因死亡率的危险因素。了解死亡风险是否可以改变,确定与高风险相关的基线特征,有助于指导医生的决策。确定二次(替换、修改或升级)CIED手术后1年全因死亡率的可改变和不可改变的危险因素。该分析包括来自WRAP-IT研究的5461例二次手术患者。候选因素包括患者和手术特点。随访1年以上的患者在1年进行审查。通过逐步选择最小化赤池信息准则,建立多变量Cox比例风险模型。二次手术后一年的总死亡率为5.2%。在分析的26例患者和18例手术特征中,以下变量最能预测1年全因死亡风险:年龄、NYHA分级、肾功能不全、抗凝剂使用、缺血性心肌病、糖尿病、BMI、手术时间、心肌梗死、瓣膜手术和肥厚性心肌病(表)。在接受二次手术的WRAP-IT患者中,唯一与全因1年死亡率风险相关的手术特征是手术时间,这表明大多数死亡率风险因素是不可改变的。基线患者特征和合并症是1年全因死亡率的主要危险因素。具体来说,年龄增加、NYHA分级和肾功能不全史与死亡率密切相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信